What stocks does Nippon India Pharma Fund hold?

Nippon India Pharma Fund holds a portfolio of Indian equity stocks disclosed monthly by Nippon India Mutual Fund to AMFI. The complete current holdings with weights and month-over-month changes are available on this page. Data is sourced from official AMFI portfolio disclosures.

Which AMC manages Nippon India Pharma Fund?

Nippon India Pharma Fund is managed by Nippon India Mutual Fund, a SEBI-registered Asset Management Company in India.

What category is Nippon India Pharma Fund?

Nippon India Pharma Fund is classified as a Equity mutual fund under SEBI's mutual fund categorisation framework.

How often is Nippon India Pharma Fund portfolio data updated?

Portfolio holdings for Nippon India Pharma Fund are updated monthly. SEBI mandates all AMCs to disclose their complete portfolio within 10 days of each month end. RightAdvise sources this data directly from official AMFI portfolio disclosures.

← Nippon India Mutual Fund

Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option

Equity Data as of Apr 2026 Comparing Mar 2026 → Apr 2026

Share: WhatsApp X

Stocks Held

Apr 2026

Equity Holdings

₹8,255.15 Cr

Equity only, excl. debt & cash

Top 5 Weight

40.9%

High concentration

Top 10 Weight

59.5%

Moderate

Changes

0 new · 1 exits

Top Sector

Pharmaceuticals & Biotechnology

73.6% of portfolio

📋 What Happened This Month Nippon India Pharma Fund exited 1 stock from its portfolio this month. JB Chemicals & Pharmaceuticals Limited was the biggest exit (Pharmaceuticals & Biotechnology), which was held at 2.09%. Among existing holdings, Dr. Reddy's Laboratories Limited saw the biggest increase — now at 7.04% of the portfolio. Lupin Limited was trimmed the most, now at 7.95%. Sun Pharmaceutical Industries Limited remains the top holding with Pharmaceuticals & Biotechnology the dominant sector at 73.6%. ↓ Scroll down for full holdings, sector allocation and month-on-month changes in detail.

NAV Performance

1 year history · Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option

-0.58%

+4.18%

+3.50%

+5.34%

Latest NAV

₹596.02

04 Jun 2026

52W High

₹616.39

-3% from High

52W Low

₹501.48

+19% from Low

Calendar Year Returns

Jan 1 to Dec 31 each year. Simple point-to-point — not CAGR.

2025

-2.5%

2024

+35.3%

2023

+40.4%

2022

-9.1%

2021

+25.1%

2020

+67.9%

2019

+2.5%

2018

+4.6%

2017

+8.6%

Rolling Returns

Performance across every possible investment start date.

1Y Rolling Avg

18.6%

+ve in 74% windows

88.4% / -14.9%

3Y Rolling Avg

19.2% p.a.

+ve in 99% windows

33.5% / -1.6%

5Y Rolling Avg

20.4% p.a.

+ve in 100% windows

32.2% / 12.3%

Crisis Period Behaviour

"Pre-inception" = fund didn't exist during that period.

2024–25 Tariff

-14.7%

Rec: Jul 2025 (7 mo)

COVID-19 Crash

-21.2%

Rec: Apr 2020 (1 mo)

2022 Rate Hike

-16.1%

Rec: Jun 2023 (1yr 5mo)

2018 IL&FS

-11.3%

Rec: Feb 2020 (1yr 11mo)

Risk Ratios

3 years daily NAV · Risk-free rate 6.5% p.a. What do these mean? →

Sharpe Ratio (3Y)

1.37

Return per unit of risk. >1 is good.

Sortino Ratio (3Y)

2.03

Penalises downside volatility only.

Std Deviation (3Y)

13.0%

Lower = more consistent returns.

NAV Chart ₹596.02 04 Jun 2026

Simple Moving Avg: Click to draw · click again to remove

Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option

Chart shows indexed performance (base = 100). Actual NAV: ₹596.02

Sector Shift Industry allocation month-over-month

Feb 2026 → Mar 2026

Sector	Prev	Curr ▼	Delta
Pharmaceuticals & Biotechnology	74.4%	75.3%	▲ +0.9%
Healthcare Services	21.6%	20.3%	▼ -1.3%
Retailing	3.7%	3.9%	▲ +0.2%

Mar 2026 → Apr 2026

Sector	Prev	Curr ▼	Delta
Pharmaceuticals & Biotechnology	75.3%	73.6%	▼ -1.7%
Healthcare Services	20.3%	21.3%	▲ +1.0%
Retailing	3.9%	3.8%	● -0.1%

🔴

Biggest Exit

JB Chemicals & Pharmaceuticals Limited

2.09% was held · Pharmaceuticals & Biotechnology

↑

Biggest Add

Dr. Reddy's Laboratories Limited

+1.08% · now 7.04%

↓

Biggest Trim

Lupin Limited

-0.50% · now 7.95%

👋 Other funds also exited

JB Chemicals & Pharmaceuticals Limited 1 fund

What Changed?

Comparing Mar 2026 → Apr 2026

Mar 2026 → Apr 2026

🔴 1 Exit ↑ 17 Increased ↓ 16 Decreased

#	Stock	Sector	Last Weight (Mar 2026)
1	JB Chemicals & Pharmaceuticals Limited ₹165.08 Cr	Pharmaceuticals & Biotechnology	2.09%

#	Stock	Sector	Mar 2026	Apr 2026	Change
1	Dr. Reddy's Laboratories Limited ₹588.66 Cr	Pharmaceuticals & Biotechnology	5.96%	7.04%	+1.08%
2	Syngene International Limited ₹119.76 Cr	Healthcare Services	0.93%	1.43%	+0.50%
3	Vijaya Diagnostic Centre Limited ₹280.90 Cr	Healthcare Services	3.15%	3.36%	+0.21%
4	Divi's Laboratories Limited ₹553.20 Cr	Pharmaceuticals & Biotechnology	6.41%	6.61%	+0.20%
5	Suraksha Diagnostic Ltd ₹110.64 Cr	Healthcare Services	1.12%	1.32%	+0.20%
6	Mankind Pharma Limited ₹254.15 Cr	Pharmaceuticals & Biotechnology	2.87%	3.04%	+0.17%
7	Thyrocare Technologies Limited ₹176.14 Cr	Healthcare Services	1.94%	2.11%	+0.17%
8	Sai Life Sciences Limited ₹273.32 Cr	Pharmaceuticals & Biotechnology	3.15%	3.27%	+0.12%
9	Fortis Healthcare Limited ₹101.88 Cr	Healthcare Services	1.11%	1.22%	+0.11%
10	Akums Drugs and Pharmaceuticals Limited ₹82.93 Cr	Pharmaceuticals & Biotechnology	0.89%	0.99%	+0.10%
11	Anthem Biosciences Limited ₹80.46 Cr	Pharmaceuticals & Biotechnology	0.88%	0.96%	+0.08%
12	Indoco Remedies Ltd ₹38.44 Cr	Pharmaceuticals & Biotechnology	0.38%	0.46%	+0.08%
13	Narayana Hrudayalaya Limited ₹145.55 Cr	Healthcare Services	1.67%	1.74%	+0.07%
14	SANOFI CONSUMER HEALTHCARE ₹101.79 Cr	Pharmaceuticals & Biotechnology	1.16%	1.22%	+0.06%
15	Cipla Limited ₹457.71 Cr	Pharmaceuticals & Biotechnology	5.42%	5.47%	+0.05%
16	Aurobindo Pharma Limited ₹236.58 Cr	Pharmaceuticals & Biotechnology	2.81%	2.83%	+0.02%
17	Concord Biotech Limited ₹12.76 Cr	Pharmaceuticals & Biotechnology	0.14%	0.15%	+0.01%

#	Stock	Sector	Mar 2026	Apr 2026	Change
1	Lupin Limited ₹664.82 Cr	Pharmaceuticals & Biotechnology	8.45%	7.95%	-0.50%
2	IPCA Laboratories Limited ₹208.93 Cr	Pharmaceuticals & Biotechnology	2.77%	2.50%	-0.27%
3	Ajanta Pharma Limited ₹267.12 Cr	Pharmaceuticals & Biotechnology	3.36%	3.19%	-0.17%
4	Abbott India Limited ₹188.69 Cr	Pharmaceuticals & Biotechnology	2.43%	2.26%	-0.17%
5	Apollo Hospitals Enterprise Limited ₹419.09 Cr	Healthcare Services	5.15%	5.01%	-0.14%
6	Pfizer Limited ₹149.91 Cr	Pharmaceuticals & Biotechnology	1.90%	1.79%	-0.11%
7	GlaxoSmithKline Pharmaceuticals Limited ₹213.37 Cr	Pharmaceuticals & Biotechnology	2.64%	2.55%	-0.09%
8	MedPlus Health Services Limited ₹316.35 Cr	Retailing	3.86%	3.78%	-0.08%
9	Max Healthcare Institute Limited ₹263.96 Cr	Healthcare Services	3.24%	3.16%	-0.08%
10	Alkem Laboratories Limited ₹174.79 Cr	Pharmaceuticals & Biotechnology	2.17%	2.09%	-0.08%
11	Sun Pharmaceutical Industries Limited ₹1,158.46 Cr	Pharmaceuticals & Biotechnology	13.92%	13.85%	-0.07%
12	Gland Pharma Limited ₹140.16 Cr	Pharmaceuticals & Biotechnology	1.72%	1.68%	-0.04%
13	Biocon Limited ₹52.85 Cr	Pharmaceuticals & Biotechnology	0.67%	0.63%	-0.04%
14	Dr. Lal Path Labs Limited ₹166.56 Cr	Healthcare Services	2.02%	1.99%	-0.03%
15	Emcure Pharmaceuticals Limited ₹125.39 Cr	Pharmaceuticals & Biotechnology	1.51%	1.50%	-0.01%
16	AstraZeneca Pharma India Limited ₹51.39 Cr	Pharmaceuticals & Biotechnology	0.62%	0.61%	-0.01%

Full Portfolio

34 stocks — Apr 2026

#	Stock	Sector	Weight & Value
1	Sun Pharmaceutical Industries Limited ₹1,158.46 Cr	Pharmaceuticals & Biotechnology	13.85%
2	Lupin Limited ₹664.82 Cr	Pharmaceuticals & Biotechnology	7.95%
3	Dr. Reddy's Laboratories Limited ₹588.66 Cr	Pharmaceuticals & Biotechnology	7.04%
4	Divi's Laboratories Limited ₹553.20 Cr	Pharmaceuticals & Biotechnology	6.61%
5	Cipla Limited ₹457.71 Cr	Pharmaceuticals & Biotechnology	5.47%
6	Apollo Hospitals Enterprise Limited ₹419.09 Cr	Healthcare Services	5.01%
7	MedPlus Health Services Limited ₹316.35 Cr	Retailing	3.78%
8	Vijaya Diagnostic Centre Limited ₹280.90 Cr	Healthcare Services	3.36%
9	Sai Life Sciences Limited ₹273.32 Cr	Pharmaceuticals & Biotechnology	3.27%
10	Ajanta Pharma Limited ₹267.12 Cr	Pharmaceuticals & Biotechnology	3.19%
11	Max Healthcare Institute Limited ₹263.96 Cr	Healthcare Services	3.16%
12	Mankind Pharma Limited ₹254.15 Cr	Pharmaceuticals & Biotechnology	3.04%
13	Aurobindo Pharma Limited ₹236.58 Cr	Pharmaceuticals & Biotechnology	2.83%
14	GlaxoSmithKline Pharmaceuticals Limited ₹213.37 Cr	Pharmaceuticals & Biotechnology	2.55%
15	IPCA Laboratories Limited ₹208.93 Cr	Pharmaceuticals & Biotechnology	2.50%
16	Abbott India Limited ₹188.69 Cr	Pharmaceuticals & Biotechnology	2.26%
17	Thyrocare Technologies Limited ₹176.14 Cr	Healthcare Services	2.11%
18	Alkem Laboratories Limited ₹174.79 Cr	Pharmaceuticals & Biotechnology	2.09%
19	Dr. Lal Path Labs Limited ₹166.56 Cr	Healthcare Services	1.99%
20	Pfizer Limited ₹149.91 Cr	Pharmaceuticals & Biotechnology	1.79%
21	Narayana Hrudayalaya Limited ₹145.55 Cr	Healthcare Services	1.74%
22	Gland Pharma Limited ₹140.16 Cr	Pharmaceuticals & Biotechnology	1.68%
23	Emcure Pharmaceuticals Limited ₹125.39 Cr	Pharmaceuticals & Biotechnology	1.50%
24	Syngene International Limited ₹119.76 Cr	Healthcare Services	1.43%
25	Suraksha Diagnostic Ltd ₹110.64 Cr	Healthcare Services	1.32%
26	Fortis Healthcare Limited ₹101.88 Cr	Healthcare Services	1.22%
27	SANOFI CONSUMER HEALTHCARE ₹101.79 Cr	Pharmaceuticals & Biotechnology	1.22%
28	Akums Drugs and Pharmaceuticals Limited ₹82.93 Cr	Pharmaceuticals & Biotechnology	0.99%
29	Anthem Biosciences Limited ₹80.46 Cr	Pharmaceuticals & Biotechnology	0.96%
30	Sanofi India Limited ₹78.46 Cr	Pharmaceuticals & Biotechnology	0.94%
31	Biocon Limited ₹52.85 Cr	Pharmaceuticals & Biotechnology	0.63%
32	AstraZeneca Pharma India Limited ₹51.39 Cr	Pharmaceuticals & Biotechnology	0.61%
33	Indoco Remedies Ltd ₹38.44 Cr	Pharmaceuticals & Biotechnology	0.46%
34	Concord Biotech Limited ₹12.76 Cr	Pharmaceuticals & Biotechnology	0.15%